PURPOSE: B vitamins and methionine have been postulated to have potential effects on carcinogenesis; however, findings from previous epidemiologic studies on B vitamins, methionine, and lung cancer risk are inconsistent. We investigated associations of dietary intakes of B vitamins (i.e., riboflavin, niacin, vitamin B6, folate, and vitamin B12) and methionine with lung cancer risk among female never smokers. METHODS: The Shanghai Women's Health Study, a population-based, prospective cohort study, included 74,941 women. During a median follow-up of 11.2 years, 428 incident lung cancer cases accrued among 71,267 women with no history of smoking or cancer at baseline. Baseline dietary intakes were derived from a validated, interviewer-administered food frequency questionnaire. Cancer incidence and vital status were ascertained through annual linkage to the Shanghai Cancer Registry and Shanghai Vital Statistics Registry databases and through biennial in-person follow-ups with participants. Adjusted hazard ratios (HR) and 95 % confidence intervals (CI) were calculated using Cox regression. RESULTS: Dietary riboflavin intake was inversely associated with lung cancer risk (HR = 0.62; 95 % CI = 0.43-0.89; p trend = 0.03 for the highest quartile compared with the lowest). A higher than median intake of methionine was associated with lower risk of lung cancer (HR = 0.78; 95 % CI = 0.60-0.99); however, there was no dose-response relation. Intakes of other B vitamins were not associated with lung cancer risk. CONCLUSIONS: Our study suggests that dietary riboflavin intake may be inversely associated with lung cancer risk among female never smokers, which warrants further investigation.
PURPOSE: B vitamins and methionine have been postulated to have potential effects on carcinogenesis; however, findings from previous epidemiologic studies on B vitamins, methionine, and lung cancer risk are inconsistent. We investigated associations of dietary intakes of B vitamins (i.e., riboflavin, niacin, vitamin B6, folate, and vitamin B12) and methionine with lung cancer risk among female never smokers. METHODS: The Shanghai Women's Health Study, a population-based, prospective cohort study, included 74,941 women. During a median follow-up of 11.2 years, 428 incident lung cancer cases accrued among 71,267 women with no history of smoking or cancer at baseline. Baseline dietary intakes were derived from a validated, interviewer-administered food frequency questionnaire. Cancer incidence and vital status were ascertained through annual linkage to the Shanghai Cancer Registry and Shanghai Vital Statistics Registry databases and through biennial in-person follow-ups with participants. Adjusted hazard ratios (HR) and 95 % confidence intervals (CI) were calculated using Cox regression. RESULTS: Dietary riboflavin intake was inversely associated with lung cancer risk (HR = 0.62; 95 % CI = 0.43-0.89; p trend = 0.03 for the highest quartile compared with the lowest). A higher than median intake of methionine was associated with lower risk of lung cancer (HR = 0.78; 95 % CI = 0.60-0.99); however, there was no dose-response relation. Intakes of other B vitamins were not associated with lung cancer risk. CONCLUSIONS: Our study suggests that dietary riboflavin intake may be inversely associated with lung cancer risk among female never smokers, which warrants further investigation.
Authors: Eunyoung Cho; David J Hunter; Donna Spiegelman; Demetrius Albanes; W Lawrence Beeson; Piet A van den Brandt; Graham A Colditz; Diane Feskanich; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Anthony B Miller; Thomas E Rohan; Thomas A Sellers; Jarmo Virtamo; Walter C Willett; Stephanie A Smith-Warner Journal: Int J Cancer Date: 2006-02-15 Impact factor: 7.396
Authors: Enrico Rossi; Joseph Hung; John P Beilby; Matthew W Knuiman; Mark L Divitini; Helen Bartholomew Journal: Ann Epidemiol Date: 2005-12-15 Impact factor: 3.797
Authors: Farin Kamangar; You-Lin Qiao; Binbing Yu; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Steven D Mark; Ping Zhao; Sanford M Dawsey; Philip R Taylor Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-08 Impact factor: 4.254
Authors: E V Bandera; J L Freudenheim; J R Marshall; M Zielezny; R L Priore; J Brasure; M Baptiste; S Graham Journal: Cancer Causes Control Date: 1997-11 Impact factor: 2.506
Authors: Hongbing Shen; Qingyi Wei; Patricia C Pillow; Christopher I Amos; Waun K Hong; Margaret R Spitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-10 Impact factor: 4.254